Laryngeal Diseases: Clinical Trials

779 trials for Laryngeal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

388 completed, 121 unknown, 106 recruiting, 65 terminated. 306 Not applicable, 139 Phase 2, 68 Phase 1, 64 Phase 3, 33 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable306Completed 163, Unknown 47, Recruiting 36, Terminated 24, Not yet recruiting 16, Withdrawn 10, Active not recruiting 6, Enrolling by invitation 3, Suspended 1
Phase 2139Completed 61, Recruiting 24, Terminated 18, Unknown 14, Active not recruiting 11, Withdrawn 6, Not yet recruiting 5
Phase 168Completed 37, Recruiting 9, Terminated 6, Unknown 5, Active not recruiting 4, Withdrawn 4, Not yet recruiting 3
Phase 364Completed 30, Terminated 10, Recruiting 9, Active not recruiting 7, Unknown 5, Withdrawn 2, Not yet recruiting 1
Phase 433Completed 16, Unknown 6, Terminated 5, Recruiting 3, Withdrawn 3
Early Phase 113Completed 6, Recruiting 5, Terminated 1, Unknown 1

Follow Laryngeal Diseases: new trials by email Literature Review of Laryngeal Diseases trials Research Report on Laryngeal Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Personalized Voice Restoration Device for Patients With Laryngectomy
Surface Electromyography - Dysphonia, Aphonia
Not applicableNot yet recruitingWeill Medical College of Cornell University1002027-12-012026-06-16
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)392027-02-132026-09-03
Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures
Ultrasound for cough, Ultrasound for vocal fold atrophy or vocal fold paresis/paralysis, Ultrasound for dysphagia - Cough, Vocal Cord Atrophy
Not applicableNot yet recruitingWeill Medical College of Cornell University2002027-01-012026-06-16
Effect Of Intracuff Dexamethasone On Postoperative Sore Throat In Patients Undergoing Laparoscopic Cholecystectomy
Dexamethasone (0.1 mg/kg), Normal Saline (0.9% NaCl) - Postoperative Sore Throat, Cough, Hoarseness
Not applicableNot yet recruitingB.P. Koirala Institute of Health Sciences402027-01-012026-08-24
Single Dose 4-Aminopyridine for Diagnosing Recurrent Laryngeal Nerve Paralysis Continuity After Trauma
4-Aminopyridine - Vocal Cord Paralysis, Recurrent Laryngeal Nerve Palsy
Phase 1Not yet recruitingMilton S. Hershey Medical Center502026-12-012026-09-21
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
Cheung-Bearelly Aesthesiometer, Transnasal Laryngoscopy, Questionnaires - Presbylarynx, Aspiration
Not applicableNot yet recruitingUniversity of California, San Francisco402026-11-012026-09-18
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
PRGN-2012, Bevacizumab - Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
Phase 2Not yet recruitingNational Cancer Institute (NCI)502026-10-282026-10-23
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
SX-682, DTX - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)1202026-10-282026-10-23
Irrigation Fluid Volume, Tube Cuff Pressure, and Neck Swelling During Shoulder Arthroscopy
Elective Shoulder Arthroscopy - Shoulder Arthroscopy, Endotracheal Tube Cuff Pressure
Not yet recruitingFatih Sultan Mehmet Training and Research Hospital602026-10-152026-10-01
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction
Fosamprenavir Calcium, Placebo - Laryngopharyngeal Reflux
Phase 2RecruitingMedical College of Wisconsin1042026-10-012026-09-10
Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
sodium oxybate - Spasmodic Dysphonia, Laryngeal Dystonia
Phase 1Not yet recruitingKristina Simonyan82026-10-012026-04-28
Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma
Panitumumab-IRDye800, [18F]NOTA-ABY-030 - HNSCC,Larynx, Pharynx and Oral Cavity, Squamous Cell Carcinoma
Phase 1RecruitingVanderbilt-Ingram Cancer Center302026-10-012026-10-19
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Hypofractionated Stereotactic Body Radiotherapy (SBRT), Pembrolizumab, Ficerafusp alfa - Head and Neck Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma
Phase 1 / Phase 2Not yet recruitingWashington University School of Medicine452026-09-302026-08-13
Effects of Video LMA Cuff Pressure in Tympanoplasty.
Oropharyngeal Leak Pressure, Airway Management
Not yet recruitingSamsun University482026-09-252026-09-30
Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
Electronic Health Record Review, Fentanyl, Laryngoscopy - Head and Neck Carcinoma, Hypopharyngeal Carcinoma
Phase 4RecruitingOHSU Knight Cancer Institute582026-09-222026-10-05
A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
Ficerafusp alfa, Pembrolizumab (KEYTRUDA®) - Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2RecruitingBicara Therapeutics1602026-09-012026-10-13
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac Surgery
Intraoperative laryngeal nerve monitor - Unilateral Vocal Cord Paralysis, Unilateral Vocal Cord Paresis
Not applicableNot yet recruitingUniversity of Alberta902026-09-012026-05-22
Thermotherapy for Head and Neck Cancer Patients
Thermotherapy, Radiotherapy, Concurrent chemoradiation - Head and Neck Cancer, Oropharyngeal Carcinoma
Phase 1RecruitingErasmus Medical Center302026-09-012026-09-02
Active vs. Passive VR During Office-based ENT Procedures
Passive virtual reality headset or goggles, Active virtual reality headset or goggles - Pain, Anxiety
Not applicableNot yet recruitingCedars-Sinai Medical Center1322026-09-012026-08-17
Effects of Therapeutic Exercise With and Without Nerve Stimulation on Dysphonia in Post Thyroidectomy Patients
therapeutic exercise, therapeutic exercise + transcutaneous nerve stimulation - Post-Thyroidectomy Dysphonia
Not applicableNot yet recruitingUniversity of Lahore602026-09-012026-09-09

Showing 20 of 779. Sign in to see all of them.

Narrower conditions

Laryngeal Neoplasms (256)  ·  Head and Neck Neoplasms (132)  ·  Hypopharyngeal Neoplasms (120)  ·  Dysphonia (116)  ·  Mouth Neoplasms (111)  ·  Oropharyngeal Neoplasms (108)  ·  Squamous Cell Carcinoma of Head and Neck (84)  ·  Voice Disorders (69)  ·  Vocal Cord Paralysis (57)  ·  Laryngopharyngeal Reflux (53)  ·  Hoarseness (51)  ·  Nasopharyngeal Neoplasms (45)  ·  Deglutition Disorders (39)  ·  Carcinoma (36)

Broader conditions

Respiratory Tract Diseases (779)  ·  Otorhinolaryngologic Diseases (739)  ·  Pathological Conditions, Signs and Symptoms (352)  ·  Neoplasms by Site (321)  ·  Signs and Symptoms (314)  ·  Neoplasms (307)  ·  Nervous System Diseases (300)  ·  Neurologic Manifestations (281)  ·  Otorhinolaryngologic Neoplasms (260)  ·  Respiratory Tract Neoplasms (259)  ·  Pharyngeal Diseases (220)  ·  Stomatognathic Diseases (206)  ·  Head and Neck Neoplasms (186)  ·  Digestive System Diseases (150)

Interventions

Cisplatin (47)  ·  Radiotherapy (30)  ·  Cetuximab (27)  ·  Magnetic Resonance Spectroscopy (19)  ·  pembrolizumab (17)  ·  Docetaxel (16)  ·  Fluorouracil (16)  ·  Carboplatin (15)  ·  Dexamethasone (15)  ·  Specimen Handling (15)  ·  Radiotherapy, Intensity-Modulated (14)  ·  1,2-diaminocyclohexaneplatinum II citrate (10)  ·  Drug Therapy (9)  ·  Lansoprazole (9)  ·  Laryngoscopy (9)

Sponsors

National Cancer Institute (NCI) (19)  ·  Mayo Clinic (10)  ·  Emory University (9)  ·  M.D. Anderson Cancer Center (9)  ·  University Hospital Ostrava (9)  ·  Memorial Sloan Kettering Cancer Center (8)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (8)  ·  Seoul National University Hospital (8)  ·  University of California, San Francisco (8)  ·  Washington University School of Medicine (8)  ·  University of Chicago (7)  ·  University of Minnesota (7)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (6)  ·  Massachusetts Eye and Ear Infirmary (6)  ·  Roswell Park Cancer Institute (6)

Countries

United States (336)  ·  France (50)  ·  Turkey (Türkiye) (37)  ·  China (35)  ·  Canada (30)  ·  Italy (29)  ·  United Kingdom (28)  ·  South Korea (27)  ·  Germany (24)  ·  Taiwan (21)  ·  Belgium (20)  ·  Egypt (17)  ·  Netherlands (17)  ·  Spain (17)  ·  Poland (16)

Top investigators

Kristina Simonyan, MD, PhD (9)  ·  Adam Luginbuhl, MD (3)  ·  Clark Rosen, MD (3)  ·  Frans JM Hilgers, MD, PhD (3)  ·  Jennifer Johnson, MD, PhD (3)  ·  Andrew Sikora, MD, PhD (2)  ·  Benjamin Lallemant, MD (2)  ·  Bo Chawes, PhD (2)  ·  Carter Van Waes, M.D. (2)  ·  Ching-Ting Tan, MD, PhD (2)  ·  Christian Debry, MD (2)  ·  David Lott, MD (2)  ·  Edward J. Damrose MD, FACS (2)

Results publications

PMID 19140539, PMID 26679193, PMID 26787799, PMID 27939583, PMID 28674168, PMID 29408585, PMID 39740942, PMID 10562789, PMID 10924966, PMID 11127145, PMID 11190378, PMID 11391740, PMID 11432181, PMID 11566828, PMID 11725167, PMID 11804862, PMID 12150380, PMID 12161727, PMID 12434607, PMID 14511925, PMID 14557228, PMID 14668816, PMID 14718713, PMID 15051621, PMID 15210907, PMID 15225175, PMID 15387083, PMID 16112543, PMID 16481828, PMID 16537737, PMID 16597660, PMID 16672085, PMID 16794899, PMID 16823067, PMID 16849759, PMID 16855994, PMID 16931978, PMID 17044539, PMID 17293228, PMID 17537681, PMID 17589721, PMID 17709149, PMID 17721405, PMID 17767636, PMID 17822322, PMID 17906496, PMID 17922287, PMID 18315632, PMID 18334848, PMID 19018337

NIH funding

2023 (4), P30CA138292 (4), U10CA180820 (4), U10CA180868 (4), 2019 (2), P30CA015083 (2), P30CA016056 (2), R01DC012545 (2), UM1CA186690 (2), 2008 (1), 2014 (1), 2015 (1), 2016 (1), 2025 (1), K01AT004415 (1)